Fortaleza Asset Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Fortaleza Asset Management’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-6,717	Closed	-$66K	–	228
2015 Q1	$66K	Sell	6,717 -9,998	-60%	-$125K	0.04%	162
2014 Q4	$205K	Buy	+16,715	New	+$204K	0.09%	163
2013 Q3	–	Sell	-71,200	Closed	-$582K	–	229
2013 Q2	$582K	Buy	+71,200	New	+$544K	0.34%	119

Other funds holding ACHN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Fortaleza Asset Management's ACHN Position: Q2 2015 in Review

Fortaleza Asset Management sold out of Achillion Pharmaceuticals (ACHN) in Q2 2015, closing a stake of 6,717 shares — an estimated $66K sold.

Fortaleza Asset Management first reported a position in ACHN in Q2 2013 and held it in 3 quarters. The position peaked at $582K in Q2 2013. 158 funds tracked by Wall St. Rank hold ACHN as of Q2 2015.

Fortaleza Asset Management reported no remaining Achillion Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
Fortaleza Asset Management sold 6,717 Achillion Pharmaceuticals shares in Q2 2015, an estimated $66K.
Fortaleza Asset Management first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 3 quarters.
Fortaleza Asset Management's Achillion Pharmaceuticals position peaked at $582K in Q2 2013.
158 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q2 2015.

Based on Fortaleza Asset Management's 13F filing for Q2 2015, filed 28 Jul 2015.